Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $14.28 USD
Change Today 0.00 / 0.00%
Volume 1.3M
IMGN On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Daniel M. Junius

Chief Executive Officer, President and Director,ImmunoGen, Inc.
AgeTotal Calculated CompensationThis person is connected to 23 board members in 3 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Daniel M. Junius, also known as Dan, has been the Chief Executive Officer and President at ImmunoGen, Inc. January 1, 2009. Mr. Junius served as an Acting Chief Financial Officer of ImmunoGen, Inc. from September 13, 2013 to December 30, 2013. He joined ImmunoGen in May 2005 and served as its Acting Chief Financial Officer from July 2008 to January 2009, Executive Vice President from July 2006 to July 2008, Treasurer until July 2008, Principal Accounting Officer ...

Read Full Background

Corporate Headquarters*

830 Winter Street
Waltham, Massachusetts 02451

United States

Phone: 781-895-0600
Fax: 781-895-0611

Board Members Memberships*

Chief Executive Officer, President and Director
Director, Chairman of Audit Committee and Member of Finance Committee


Boston College
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$544,500

Stock Options*

All Other Compensation$8,184
Exercised Options102,301
Exercised Options Value$1,123,092
Exercisable Options1,016,363
Exercisable Options Value$4,374,008
Unexercisable Options385,000
Total Value of Options$5,497,099
Total Number of Options1,503,664

Total Compensation*

Total Annual Cash Compensation$863,049
Total Short Term Compensation$544,500
Other Long Term Compensation$8,184
Total Calculated Compensation$3,111,584
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMGN:US $14.28 USD 0.00


Simon E. Moroney Ph.D.Chairman of Management Board and Chief Executive Officer
Morphosys AG
Michael S. O. Oredsson B.Int’l Bus Admin (Lund)Chief Executive Officer and President
BioInvent International AB
Nobuo Hanai Ph.D.Chief Executive Officer, President and Representative Director
Kyowa Hakko Kirin Co., Ltd.
Edwin Moses Ph.D.Chief Executive Officer, Director and Member of Research & Development Committee
Ablynx NV
William John Edward Burt DPhilChief Executive Officer and Executive Director
Abzena plc
255.0K GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at